Literature DB >> 18535871

The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation.

Carlo Cereda, Thierry Kuntzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18535871     DOI： 10.1007/s00415-008-0856-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Cardiovascular effects of ephedra alkaloids: a comprehensive review.

Authors:  Richard Andraws; Preety Chawla; David L Brown
Journal:  Prog Cardiovasc Dis       Date:  2005 Jan-Feb       Impact factor: 8.194

2.  Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

Authors:  Paul G Shekelle; Mary L Hardy; Sally C Morton; Margaret Maglione; Walter A Mojica; Marika J Suttorp; Shannon L Rhodes; Lara Jungvig; James Gagné
Journal:  JAMA       Date:  2003-03-10       Impact factor: 56.272

3.  Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.

Authors:  M Bestue-Cardiel; A Sáenz de Cabezón-Alvarez; J L Capablo-Liesa; J López-Pisón; J L Peña-Segura; J Martin-Martinez; A G Engel
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

4.  Ephedrine in the treatment of congenital myasthenic syndrome.

Authors:  K J Felice; G M Relva
Journal:  Muscle Nerve       Date:  1996-06       Impact factor: 3.217

Review 5.  Treatment for Lambert-Eaton myasthenic syndrome.

Authors:  P Maddison; J Newsom-Davis
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

6.  Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol.

Authors:  M Milone; A G Engel
Journal:  Brain Res       Date:  1996-11-18       Impact factor: 3.252

7.  Effect of ephedrine on muscle weakness in a model of myasthenia gravis in rats.

Authors:  P C Molenaar; J E Biewenga; G T Van Kempen; J A De Priester
Journal:  Neuropharmacology       Date:  1993-04       Impact factor: 5.250

8.  Ephedrine: effects on neuromuscular transmission.

Authors:  J P Sieb; A G Engel
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

9.  Muscle membrane polarisation after provocative tests, and after cooling: the normal CMAP changes to be expected.

Authors:  Thierry Kuntzer; Patrik Michel
Journal:  Clin Neurophysiol       Date:  2004-06       Impact factor: 3.708

Review 10.  Myasthenia gravis: review of diagnosis and management.

Authors:  B M Patten
Journal:  Muscle Nerve       Date:  1978 May-Jun       Impact factor: 3.217
  10 in total
  1 in total

1.  Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations.

Authors:  Menachem Sadeh; Xin-Ming Shen; Andrew G Engel
Journal:  Muscle Nerve       Date:  2011-06-30       Impact factor: 3.217
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.